A Study of the Effect Efavirenz on the Plasma Levels of MK-7602 in Healthy Participants (MK-7602-005)
Clinical trial NCT06797674 · COMPLETED
Trial details
- NCT number
- NCT06797674
- Sponsor
- Merck Sharp & Dohme LLC
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2025-02-10
- Primary completion
- 2025-08-12
- Enrollment
- 34
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.